BackAccustem Sciences Overview

Accustem Sciences Accounts Payable

Latest accounts payable for ACUT: $640K.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$640022.00
↓ 30.67% YoYΔ $-283169.00 vs prior year quarter

Peer trimmed avg / median

Loading

Accustem Sciences Accounts Payable History

Loading

Accustem Sciences vs. peers: Accounts Payable Comparison

Loading

Accustem Sciences Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Accustem Sciences (ACUT) FAQ

Accustem Sciences (ACUT) currently reports a accounts payable of $640K as of September 2026. That compares with $920K in the prior-year period — down 30.7% year over year. Use the charts on this page to explore Accustem Sciences's accounts payable history and peer comparisons.

Accustem Sciences's accounts payable decreased from $920K to $640K — a 30.7% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Accustem Sciences reported $640K in accounts payable as of September 2026. That compares with $920K in the prior-year period — down 30.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $640K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Accustem Sciences, and consider following ACUT for alerts when major investors trade the stock.

Accustem Sciences is classified in the Healthcare sector. On accounts payable, it currently shows $640K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ACUT with unrelated industries.

Questions & Answers